TIFFANIE VILLASANA: Open Payments
NPI 1922216407 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,481 in 150 payments from 25 companies in 2025. Trend: 2023 $2,008 · 2024 $2,101 · 2025 $2,481
Food & beverage: $2,439Education: $43
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 18 | $287 |
| Insulet Corporation | 26 | $247 |
| Abbott Laboratories | 14 | $209 |
| Novo Nordisk Inc | 10 | $201 |
| Currax Pharmaceuticals LLC | 20 | $168 |
| Amneal Pharmaceuticals LLC | 11 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $127 |
| Tandem Diabetes Care, Inc. | 4 | $113 |
| Lilly USA, LLC | 6 | $110 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
Products named: Korlym, Omnipod, FREESTYLE LIBRE, JARDIANCE, CONTRAVE, UNITHROID, Ozempic, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across TX — which companies pay providers there.
